Effect of hydralazine on the blood flow in tumors and normal tissues in rats

This publication has 17 references indexed in Scilit:

• Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivo
  International Journal of Hyperthermia, 1989
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin—Implications for theraphy
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Selective drug-induced reduction of blood flow in tumor transplants
  International Journal of Radiation Oncology*Biology*Physics, 1985
• Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
  JNCI Journal of the National Cancer Institute, 1984
• Theoretical feasibility of vasodilator-enhanced local tumor heating
  European Journal of Cancer and Clinical Oncology, 1982
• Enhancement of R3230AC Rat Mammary Tumor Growth and Cellular Differentiation by Dibutyryl Cyclic Adenosine Monophosphate23
  JNCI Journal of the National Cancer Institute, 1977
• THE USE OF RADIOACTIVE MICROSPHERES TO COMPARE THE EFFECTS OF HYDRALAZINE, GUANETHIDINE AND SK&F 24260 ON THE REDISTRIBUTION OF CARDIAC OUTPUT IN ANAESTHETIZED RABBITS
  British Journal of Pharmacology, 1975
• Blood flow and oxygenation of tumors in mice.II. Effects of vasodilator drugs
  Cancer, 1967
• Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator Drugs
  Acta Radiologica, 1962